Difference between revisions of "Main Page"
Jump to navigation
Jump to search
m (→QIBA NEWS) |
|||
| (194 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | |||
| − | |||
='''Quantitative Imaging Biomarkers Alliance (QIBA)'''= | ='''Quantitative Imaging Biomarkers Alliance (QIBA)'''= | ||
| − | '''QIBA Mission: Improve the value and practicality of quantitative biomarkers by reducing variability across devices, patients | + | '''QIBA Mission: Improve the value and practicality of quantitative imaging biomarkers by reducing variability across devices, sites, patients, and time.''' |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | [[Image:QIBA_WIKI_BLURB.jpg|600px]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | *[[ | + | :* [[Profiles|'''QIBA Profiles''']] standardize methods to create biomarkers that meet a claimed performance (accurate and reproducible). |
| − | *[[ | + | :* QIBA advances quantitative imaging in clinical trials and clinical practice. |
| + | :* QIBA engages researchers, healthcare professionals and industry. | ||
| + | :* '''[[QIBA Concepts]]''' & '''[[QIBA Overview]]''' & '''[[QIBA Collaborations]]''' | ||
| + | :* '''[[Stakeholder Viewpoints|Stakeholder Benefits]]''' | ||
| − | |||
| − | *[[ | + | The navigation box to the left provides access to: |
| + | * '''[[Profiles]]''' - biomarker specifications published by QIBA | ||
| + | * '''[[Committees]]''' - developing biomarker Profiles and related work | ||
| + | * '''[[Process]]es''' - guidance used by all Committees for developing Profiles and other QIBA work | ||
| + | * '''[[QIBA Profile Conformance | Conformance]]''' - Self Attestation and Certification Services | ||
| + | * '''[[QIBA News]]''' - Recent biomarker committee accomplishments, volunteer news items to share | ||
| + | * '''[[Education]]''' - Introduction to QIBA, ''QIBA Newsletter'' archive, QIBA posters and presentations, and citations | ||
| + | * '''[[Catalog|Resource Catalog]]''' - used for QIBA groundwork | ||
| + | * '''[[About QIBA|About QIBA]]''' - an at-a-glance introduction and QIBA YouTube Playlist | ||
| + | * '''[[QIBA Acknowledgments]]''' - Thank you to our volunteers! | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | ==<font color=blue>'''QIBA NEWS'''<font>== | |
| − | |||
| − | + | ''' | |
| − | + | <font color="black">QIBA is Transitioning to QUIC! | |
| − | |||
| − | + | ''' | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | = | + | <font color="black">Over the past 16 years, RSNA QIBA has become recognized as a community of representatives of healthcare professionals, medical associations, government regulatory agencies, pharmaceutical and scanner industries, conducting numerous groundwork studies, working on metrology underpinnings, and developing consensus among experts in the field to create rigorous quantitative imaging Profiles. |
| + | Since its creation, QIBA’s work has developed and demonstrated the value and practicality of quantitative imaging biomarkers, nationally and internationally. The next stage in this evolution is to expand RSNA’s quantitative imaging activities beyond development of Profiles, to work with stakeholders to focus on adoption and implementation in clinical trials and practice. The RSNA Board of Directors has created a Quantitative Imaging Committee (QUIC) to oversee this initiative. The QUIC will be comprised of radiologists, physicists, and other thought leaders from stakeholder groups, including industry, government, and partner organizations. | ||
| + | Answers to the FAQ submitted by QIBA members are provided below. | ||
| − | *[ | + | *[[Media:12.23.2023 QIBA_Accomplishments_TJH-2.PDF|QIBA Accomplishments Slides (Dr. Timothy J. Hall, PhD)]] |
| + | *[[Media:09.07.2023 LINK to FAQ PDF document2.PDF|FAQ PDF document]] | ||
| + | *[[Media:QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf |QUIC Profile Endorsement Criteria]] | ||
| + | *[[Media:QIBA Summary Abridged Version 21Dec2023-B.pdf |QIBA Summary – Abridged Version 21Dec2023]] | ||
| − | + | <font color="black">The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket | |
| − | + | Submissions Guidance for Industry and Food and Drug Administration (FDA) Staff was released on June 16, 2022, and can be accessed via the QIBA Education page: https://qibawiki.rsna.org/index.php/Education. | |
| − | |||
| − | |||
| − | + | <font color="black">QIBA Videos are now posted to RSNA's YouTube Channel! https://tinyurl.com/QIBA-YouTube-Playlist. These videos have been created by our QIBA volunteers. Learn more about RSNA’s Quantitative Imaging Biomarkers Alliance® (QIBA), which unites researchers, health care professionals and industry to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice. Please note: All QIBA promotional materials need to be reviewed and approved by RSNA. | |
| + | :[[Image:QIBA-YouTube-image.png|300px]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | <font color="black">This wiki site is used primarily by the QIBA Committees. For the more formal QIBA website, [http://www.rsna.org/qiba/ Click Here]. | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
---- | ---- | ||
| − | + | '''''Quantitative Imaging is a Work in Progress: read the [[Stakeholder Viewpoints|Stakeholder Benefits]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | ''''' | ||
Latest revision as of 22:14, 17 January 2024
Quantitative Imaging Biomarkers Alliance (QIBA)
QIBA Mission: Improve the value and practicality of quantitative imaging biomarkers by reducing variability across devices, sites, patients, and time.
- QIBA Profiles standardize methods to create biomarkers that meet a claimed performance (accurate and reproducible).
- QIBA advances quantitative imaging in clinical trials and clinical practice.
- QIBA engages researchers, healthcare professionals and industry.
- QIBA Concepts & QIBA Overview & QIBA Collaborations
- Stakeholder Benefits
The navigation box to the left provides access to:
- Profiles - biomarker specifications published by QIBA
- Committees - developing biomarker Profiles and related work
- Processes - guidance used by all Committees for developing Profiles and other QIBA work
- Conformance - Self Attestation and Certification Services
- QIBA News - Recent biomarker committee accomplishments, volunteer news items to share
- Education - Introduction to QIBA, QIBA Newsletter archive, QIBA posters and presentations, and citations
- Resource Catalog - used for QIBA groundwork
- About QIBA - an at-a-glance introduction and QIBA YouTube Playlist
- QIBA Acknowledgments - Thank you to our volunteers!
QIBA NEWS
QIBA is Transitioning to QUIC!
Over the past 16 years, RSNA QIBA has become recognized as a community of representatives of healthcare professionals, medical associations, government regulatory agencies, pharmaceutical and scanner industries, conducting numerous groundwork studies, working on metrology underpinnings, and developing consensus among experts in the field to create rigorous quantitative imaging Profiles. Since its creation, QIBA’s work has developed and demonstrated the value and practicality of quantitative imaging biomarkers, nationally and internationally. The next stage in this evolution is to expand RSNA’s quantitative imaging activities beyond development of Profiles, to work with stakeholders to focus on adoption and implementation in clinical trials and practice. The RSNA Board of Directors has created a Quantitative Imaging Committee (QUIC) to oversee this initiative. The QUIC will be comprised of radiologists, physicists, and other thought leaders from stakeholder groups, including industry, government, and partner organizations. Answers to the FAQ submitted by QIBA members are provided below.
- QIBA Accomplishments Slides (Dr. Timothy J. Hall, PhD)
- FAQ PDF document
- QUIC Profile Endorsement Criteria
- QIBA Summary – Abridged Version 21Dec2023
The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions Guidance for Industry and Food and Drug Administration (FDA) Staff was released on June 16, 2022, and can be accessed via the QIBA Education page: https://qibawiki.rsna.org/index.php/Education.
QIBA Videos are now posted to RSNA's YouTube Channel! https://tinyurl.com/QIBA-YouTube-Playlist. These videos have been created by our QIBA volunteers. Learn more about RSNA’s Quantitative Imaging Biomarkers Alliance® (QIBA), which unites researchers, health care professionals and industry to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice. Please note: All QIBA promotional materials need to be reviewed and approved by RSNA.
This wiki site is used primarily by the QIBA Committees. For the more formal QIBA website, Click Here.
Quantitative Imaging is a Work in Progress: read the Stakeholder Benefits